CAS, Molecule.one to collaborate on advanced synthesis design technologies
In a significant development in the realm of drug discovery, CAS, a subsidiary of the American Chemical Society, has teamed up with tech-bio front-runner Molecule.one. ... Read More
Hewlett Packard Enterprise to build TSUBAME4.0 supercomputer for Tokyo Tech
Hewlett Packard Enterprise (HPE) has been chosen to construct the TSUBAME4.0 by the Tokyo Institute of Technology (Tokyo Tech) Global Scientific Information and Computing Center ... Read More
BioNTech to buy UK-based tech firm InstaDeep for AI-powered drug discovery
German biotechnology company BioNTech has agreed to acquire 100% of the remaining InstaDeep shares for an upfront consideration of around £362 million in cash and ... Read More
Equillium acquires Bioniz Therapeutics to expand immunomodulatory drug pipeline
Equillium, a Nasdaq-listed biotech company, has acquired Bioniz Therapeutics in a deal worth up to around $329 million, in a move to considerably expand its ... Read More
Roivant Sciences enters into $7.3bn merger with Montes Archimedes Acquisition
Roivant Sciences has agreed to merge with Montes Archimedes Acquisition (MAAC), a Nasdaq-listed special purpose acquisition company, in a deal that values the Swiss biopharma ... Read More
Model Medicines, Sanford Burnham Prebys forge AI-driven drug discovery partnership
AI drug discovery software company Model Medicines has signed a multi-target collaboration agreement with California-based Sanford Burnham Prebys Medical Discovery Institute for identifying and developing ... Read More
Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities
Roivant Sciences has agreed to acquire Silicon Therapeutics, a Boston-based drug design, research, and development company, for $450 million, in an all-share deal. The Swiss ... Read More
Pfizer partners with PostEra to speed up drug discovery using machine learning technology
In an exciting new development, Pfizer has teamed up with PostEra, a leading biotech company specializing in machine learning solutions for preclinical drug discovery, to ... Read More
PharmaEngine collaborates with Sentinel Oncology for cancer drug development
PharmaEngine, a Taiwanese pharmaceutical company, has entered a strategic collaboration and licensing agreement with UK-based Sentinel Oncology to accelerate the development of a promising new ... Read More
PerkinElmer acquisition of Horizon Discovery Group: A strategic move to enhance genomic and cell engineering capabilities
PerkinElmer, a leading US-based provider of life sciences and diagnostics solutions, has announced its acquisition of Horizon Discovery Group, a UK-based company specializing in cell ... Read More